Danhong Injection in the Treatment of Acute Ischemic Stroke
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Xiao-xi Du, Professor
China Food and Drug Administration
Study Director - Xing-quan Zhao, Professor
Beijing Tiantan Hospital
Principal Investigator - Yong-yan Wang, Professor
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Study Chair - Zhong Wang, Professor
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Second Artillery General Hospital of Chinese People'S Liberation Army
Beijing, Beijing Municipality, China
- Chongqing Three Gorges Central Hospital
Chongqing, Chongqing Municipality, China
- Xinqiao Hospital of Third Military Medical University
Chongqing, Chongqing Municipality, China
- Guangdong No.2 Provincial People'S Hospital
Guangzhou, Guangdong, China
- Guangzhou Hospital of Integrated Chinese and Western Medicine
Guangzhou, Guangdong, China
- the Second People'S Hospital of Shenzhen
Shenzhen, Guangdong, China
- the Second Central Hospital of Baoding City
Baoding, Hebei, China
- Affiliated Hospital of Chengde Medical University
Chengde, Hebei, China
- Handan Central Hospital
Handan, Hebei, China
- the Second Affiliated Hopital of Harbin Medical University
Harbin, Helongjiang, China
- the Second Chinese Medical Hospital of Luoyang City
Luoyang, Henan, China
- Nanshi Hospital of Nanyang
Nanyang, Henan, China
- Nanyang T.C.M. Hospital
Nanyang, Henan, China
- People'S Hospital of Zhengzhou
Zhengzhou, Henan, China
- the First Affiliated Hospital of Henan University of T.C.M.
Zhengzhou, Henan, China
- Zhengzhou No.7 People'S Hospital
Zhengzhou, Henan, China
- Zhoukou Hospital of T.C.M.
Zhoukou, Henan, China
- Fifth Hospital in Wuhan
Wuhan, Hubei, China
- Huangpi District Hospital of T.C.M.
Wuhan, Hubei, China
- Renmin Hospital of Wuhan University
Wuhan, Hubei, China
- the Central Hospital of Wuhan
Wuhan, Hubei, China
- Tianyou Hospital Affiliated To Wuhan University of Science & Technology
Wuhan, Hubei, China
- Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
- Zhongshan Hospital of Hubei Province
Wuhan, Hubei, China
- Changsha Central Hospital
Changsha, Hunan, China
- the First Hospital of Changsha
Changsha, Hunan, China
- the Second People'S Hospital of Hunan Province
Changsha, Hunan, China
- Xiangya Hospital Central-South University
Changsha, Hunan, China
- Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
- Nanjing Hospital of T.C.M.
Nanjing, Jiangsu, China
- the Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
- China-Japan Union Hospital of Jilin University
Changchun, Jilin, China
- Jilin Province People'S Hospital
Changchun, Jilin, China
- the Affiliated Hopital To Changchun University of Chinese Medicine
Changchun, Jilin, China
- the First Hospital Affiliated To Jilin University
Changchun, Jilin, China
- the Second Hospital of Jilin University
Changchun, Jilin, China
- Liaoyuan Traditional Chinese Medical Hospital
Liaoyuan, Jilin, China
- Anshan Central Hospital
Anshan, Liaoning, China
- Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoning, China
- Dandong First Hospital
Dandong, Liaoning, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2013
- Primary completion
- 10 Mar 2019
- Completion
- 27 Mar 2019
- Last update posted
- 8 Jun 2022
- Registered enrollment
- 1,503
- Registry id
- NCT01677208
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.